• Home
  • Anxo Pharmaceutical Co.
6
Oct
2026
Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026
stand 8F2
Book a meeting

Anxo Pharmaceutical Co.

About Anxo Pharmaceutical Co.

Anxo Pharmaceutical Co. was founded in 2003, we are a technology based specialty pharmaceutical company aimed on development and manufacturing of all pharmaceutical products. In order to provide high quality medicine and advanced technology of pharmaceutical manufacture, ANXO has devoted to invest state of the art equipments, and to build up professional R&D teams dedicated to develop many critical technology platforms for high quality pharmaceutical products in the global market.

Read more Show less
Certifications
  • GMP
    GMP
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less

Meet us at

  • CPHI Milan 2026

    CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
    stand 8F2
  • Country/Region:
    Taiwan
  • On CPHI since:
    2021
  • Certificates:
    1
  • Employees:
    250 - 499
Company types
Generics/Biosimilars Manufacturer
Pharmaceutical company
Contact info
Show contact info Hide contact info

Products from Anxo Pharmaceutical Co. (4)

  • Berydone 3/ 6/ 9 mg (Paliperidone)

    Product Berydone 3/ 6/ 9 mg (Paliperidone)

    Ingridient: Paliperidone 3mg/tab, Paliperidone 6mg/tab, Paliperidone 9mg/tab

    Dosage form:Controlled Osmotic Release System ER Tablet

    Indication:Atypical antipsychotic agent indicated for Treatment of schizophrenia
  • Nophos F.C. Tablet 800mg (Sevelamer Carbonate)

    Product Nophos F.C. Tablet 800mg (Sevelamer Carbonate)

    Ingridient: Sevelamer 800mg 
    Dosage form: FC Tablet

    Indication: Nophos is a phosphate binder indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease on dialysis
  • Paliperidone Palmitate Long Acting Injection (Under development)

    Product Paliperidone Palmitate Long Acting Injection (Under development)

    Ingridient: Paliperidone Palmitate

    Dosage form: Lyophilized long acting injection (monthly)

    Indication: Treatment of schizophrenia in adults and treatment of schizoaffective disorder in adults as monotherapy and as an adjunct to mood stabilizers or antidepressants.
  • Paliperidone Palmitate Long Acting Injection (under development)

    Product Paliperidone Palmitate Long Acting Injection (under development)

    Ingridient: Paliperidone Palmitate

    Dosage form:  Lyophilized Long Acting Injection (monthly)

    Indication:Treatment of schizophrenia in adults. Treatment of schizoaffective disorder in adults as monotherapy and as an adjunct to mood stabilizers or antidepressants. 
    ...